Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.

[1]  B. Masters.  Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, Eighth Edition (2015) Eds: John E. Bennett, Raphael Dolin, Martin J. Blaser. ISBN: 13-978-1-4557-4801-3, Elsevier Saunders , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  J. N. van den Anker,et al.  Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children , 2015, Clinical Pharmacokinetics.

[3]  G. Corsello,et al.  Antimicrobial therapy in neonatal intensive care unit , 2015, Italian Journal of Pediatrics.

[4]  N. Moore,et al.  Propensity-Based Study of Aminoglycoside Nephrotoxicity in Patients with Severe Sepsis or Septic Shock , 2014, Antimicrobial Agents and Chemotherapy.

[5]  V. Biran,et al.  Amikacin Maturation Model as a Marker of Renal Maturation to Predict Glomerular Filtration Rate and Vancomycin Clearance in Neonates , 2013, Clinical Pharmacokinetics.

[6]  A. Gous,et al.  Use of amikacin in neonates and related ototoxicity , 2013 .

[7]  J. Lopes,et al.  The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review , 2012, Clinical kidney journal.

[8]  R. Slaughter,et al.  Economic Impact of Aminoglycoside Toxicity and its Prevention Through Therapeutic Drug Monitoring , 1998, PharmacoEconomics.

[9]  David S. Hoff,et al.  Pharmacokinetic Outcomes of a Simplified, Weight‐Based, Extended‐Interval Gentamicin Dosing Protocol in Critically Ill Neonates , 2009, Pharmacotherapy.

[10]  J. Anker,et al.  Therapeutic Drug Monitoring of Aminoglycosides in Neonates , 2009 .

[11]  N. Medlicott,et al.  Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis , 2009, European Journal of Clinical Pharmacology.

[12]  D. Touw,et al.  Therapeutic Drug Monitoring of Aminoglycosides in Neonates , 2009, Clinical pharmacokinetics.

[13]  Jackson Roush,et al.  Year 2007 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs , 2007, Pediatrics.

[14]  J. Hearing.  Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. , 2000, Pediatrics.

[15]  H. Hurt,et al.  Extended interval dosing of gentamicin in preterm infants. , 2004, American journal of perinatology.

[16]  Ph.D. Joseph Heitman M.D.,et al.  Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2004, Mycopathologia.

[17]  E. Kamińska,et al.  [Is therapeutic drug monitoring (TDM) in paediatric patients necessary?]. , 2001, Medycyna wieku rozwojowego.

[18]  日本公定書協会.  The Japanese pharmacopoeia , 2001 .

[19]  R. Ferriols-Lisart,et al.  Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. , 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[20]  J. E. Bennett,et al.  Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2014 .

[21]  D. Gilbert.  Once-daily aminoglycoside therapy , 1991, Antimicrobial Agents and Chemotherapy.

[22]  R. Moore,et al.  Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. , 1987, The Journal of infectious diseases.

[23]  G. Haycock,et al.  Sodium homeostasis in term and preterm neonates. I. Renal aspects. , 1983, Archives of disease in childhood.

[24]  J. Desforges,et al.  Serum muramidase in newborns. , 1971, Biology of the neonate.